HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones

AIDS

Volumn 14, Issue 6, 2000, Pages 629-636

  Speth, Cornelia ^a,b   Joebstl, Barbara ^a   Barcova, Maria ^a   Dierich, Manfred P ^a  

^a Univ of I and L B l for A R   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Astrocytes; CCR5; CXCR4; gp41; HIV; Interleukin 10; Monocytes

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; ANTIBODY; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; GLYCOPROTEIN GP 41; INTERLEUKIN 10; MEMBRANE PROTEIN; RAPAMYCIN; RECOMBINANT PROTEIN; S6 KINASE; VIRUS ENVELOPE PROTEIN;

ARTICLE; ASTROCYTE; BRAIN CELL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROGLIA; MONOCYTE; NERVE CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ASTROCYTES; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; INTERLEUKIN-10; MONOCYTES; NEURONS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034008833     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200004140-00001     Document Type: Article

References (48)

1. 1. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996, 6:1-15.
2. 2. Johnson RT, Glass JD, McArthur JC, Chesebro BW. Quantitation of human immunodeficiency virus in brain of demented and nondemented patients with acquired immunodeficiency syndrome. Ann. Neurol 1996, 39:392-395.
3. 3. Sinclair E, Gray F, Ciardi A, Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropathol Exp Neurol 1994, 53:43-50.
4. 4. Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, Dierich MP. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 1991, 174:1471-1424.
5. 5. Wang H, Nishanian P, Fahey JL. Characterization of immune suppression by a synthetic HIV gp41 peptide. Cell Immunol 1995, 161:236-243.
6. 6. Barcova M, Kacani L, Speth C, Dierich MP. Gp41 envelope protein of human immunodeficiency virus induces IL-10 in monocytes, but not in B-, T-or NK-cells, leading to reduced IL-2 and IFN-gamma production. J Infect Dis 1998, 177:905-913.
7. S6-kinase activation in IL-10 up-regulation in human monocytes by gp41 envelope protein of human immunodeficiency virus type 1. Eur J Physiol 1999, 437:538-546.
8. 8. Soontornniyomkij V, Nieto-Rodriguez JA, Martinez AJ, Kingsley LA, Achim CL, Wiley CA. Brain HIV burden and length of survival after AIDS diagnosis. Clin Neuropathol 1998, 17:95-99.
9. 9. Achim CL, Wang R, Miners DK, Wiley CA. Brain viral burden in HIV infection. J Neuropathol Exp Neurol 1994, 53:284-294.
10. 10. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol 1991, 22:700-710.
11. 11. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multi-system degeneration. Acta Neuropathol 1990, 80:393-400.
12. 12. Hori K, Burd PR, Furuke K, Kutza J, Weih KA, Clouse KA. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 1999, 93:1843-1850.
13. 13. Kort JJ. Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998, 14:1329-1339.
14. 14. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921.
15. 15. Koka P, He K, Zack JA, et al. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995, 182: 941-951.
16. 16. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 1992, 66:2217-2225.
17. 17. He JL, Chen YZ, Farzan M, et al. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
18. 18. Gabuzda D, He J, Ohagen A, Vallat A. Chemokine receptors in HIV-1 infection of the central nervous system. Sem Immunol 1998, 10:203-213.
19. 19. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3 and CCR5. J Virol 1998, 72:5035-5045.
20. 20. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 1997, 151:1341-1351.
21. 21. Klein RS, Williams KC, Alvarez-Hernandez X, et al. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J Immunol 1999, 163:1636-1646.
22. 22. Ohagen A, Gosh S, He J, et al. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol 1999, 73:897-906.
23. 23. Hesselgesser J, Taub D, Baskar P, et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4. Curr Biol 1998, 8:595-598.
24. 24. Sozzani S, Ghezzi S, Iannolo G, et al. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 1998, 187:439-444.
25. 25. Patterson BK, Czerniewski M, Andersson J, et al. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin Immunol 1999, 91:254-262.
26. 26. Zou W, Foussat A, Houhou S, et al. Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. AIDS 1999, 13:455-463.
27. 27. Kutza J, Hayes MP, Clouse KA. Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5. AIDS 1998, 12:F59-F64.
28. 28. Zella D, Barabitskaja O, Burns JM, et al. Interferon-γ increases expression of chemokine receptors CCR1, CCR3 and CCR5, but not CXCR4 in monocytoid U937 cells. Blood 1998, 91: 4444-4450.
29. 29. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997, 94:1925-1939.
30. 30. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984, 81:1991-1995.
31. 31. Schols D, De Clercq E. Human immunodeficiency virus type 1 gp120 induced anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 1996, 70: 4953-4960.
32. 32. Daftarian MP, Diaz-Mitoma F, Creery WD, Cameron W, Kumar A. Dys-regulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens. Clin Diag Lab Immunol 1995, 2:712-718.
33. 33. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990, 11:176-180.
34. 34. Howard M, O'Garra A, Ishida H, de Waal-Melefyt R, de Vries J. Biological properties of interleukin 10. J Clin Immunol 1992, 12:239-247.
35. 35. Ameglio F, Cordiali-Fei P, Solmone M, et al. Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Reg Homeost Agents 1994, 8:48-52.
36. 36. Menendez-Iglesias B, Cerase J, Ceracchini C, Levi G, Aloisi F. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-γ and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J Neuroimmunol 1997, 72: 83-93.
37. 37. Kloss CUA, Kreutzberg GW, Raivich G. Proliferation of ramified microglia on an astrocyte monolayer: characterization of stimulatory and inhibitory cytokines. J Neurosci Res 1997, 49: 248-254.
38. 38. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
39. 39. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J. Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10 and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci USA 1997, 94:227-232.
40. 40. Brodie C. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes. FEBS Lett 1996, 394:117-120.
41. 41. Schluter D, Kaefer N, Hof H, Wiestler OD, Deckert-Schluter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol 1997, 150:1021-1035.
42. 42. Jander S, Pohl J, D-Urso D, Gillen C, Stoll G. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am J Pathol 1998, 152:975-982.
43. 43. Chabot S, Williams G, Hamilton M, Sutherland G, Wee Yong V. Mechanisms of IL-10 production in human microglia - T cell interaction. J Immunol 1999, 162:6819-6828.
44. 44. Thivierge M, L Gouill C, Tremblay MJ, Stankova J, Rola-Pleszczynski M. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 1998, 92:40-45.
45. 45. Ostrowski MA, Justement SJ, Catanzaro A, et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998, 161:3195-3201.
46. 46. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997, 1185:1681-1691.
47. 47. Vallat AV, De Girolami U, He J, et al. Localization of HIV-1 coreceptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 1998, 152:167-178.
48. 48. Herbein G, Mahlknecht U, Batliwalla F, et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 1998, 395:189-194.